Leap TherapeuticsLeap Therapeutics
Leap Therapeutics

Leap Therapeutics

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Website
2017Inactive
Advertise here

About

Leap Therapeutics is a biopharmaceutical company dedicated to developing and commercializing targeted and immuno-oncology therapies for patients with cancer. Their pipeline includes several promising drug candidates, with a primary focus on agents that modulate the tumor microenvironment and enhance the body's immune response against cancer cells.

Technology stack

detected 2026-05-25
Est. monthly stack spend~$70/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Leap Therapeutics do?

Leap Therapeutics is a biopharmaceutical company dedicated to developing and commercializing targeted and immuno-oncology therapies for patients with cancer. Their pipeline includes several promising drug candidates, with a primary focus on agents that modulate the tumor microenvironment and enhance the body's immune response against cancer cells.

How much funding has Leap Therapeutics raised?

Leap Therapeutics has raised a total of $189M in funding. The most recent round on record is Series C.

Where is Leap Therapeutics headquartered?

Leap Therapeutics is headquartered in Cambridge, United States.

When was Leap Therapeutics founded?

Leap Therapeutics was founded in 2017.

What industry does Leap Therapeutics operate in?

Leap Therapeutics operates in Biotech, HealthTech, Drug Discovery, Clinical Trials, Oncology, Immuno-oncology.

What is Leap Therapeutics's current status?

Leap Therapeutics's current operating status is: Inactive.